Medistim ASA 2024 AR2
The report highlights Medistim's achievements in 2024, including reaching an all-time high in sales revenue of MNOK 562.6, representing a 6.9% increase. The company successfully obtained its first CE certificates under the new EU Medical Device Regulation (MDR) for its MiraQ ultrasound systems and Transit Time Flow Measurement (TTFM) probes. In December 2024, Medistim launched the new MiraQ INTUI software platform for cardiac surgery and initiated the PATENT clinical study in vascular surgery. On the sustainability front, the company refined its ESG strategy to align with CSRD requirements, completed a double materiality assessment, and initiated Scope 1 and Scope 2 carbon footprint data collection, while implementing green fuel for airborne goods to reduce emissions.
Company: Medistim ASA
Sector: Health Care
Country: Norway
Year: 2024
Type: AR2
Pages: 126
Medistim ASA
Corporate Annual Report
The report highlights Medistim's achievements in 2024, including reaching an all-time high in sales revenue of MNOK 562.6, representing a 6.9% increase. The company successfully obtained its first CE certificates under the new EU Medical Device Regulation (MDR) for its MiraQ ultrasound systems and Transit Time Flow Measurement (TTFM) probes. In December 2024, Medistim launched the new MiraQ INTUI software platform for cardiac surgery and initiated the PATENT clinical study in vascular surgery. On the sustainability front, the company refined its ESG strategy to align with CSRD requirements, completed a double materiality assessment, and initiated Scope 1 and Scope 2 carbon footprint data collection, while implementing green fuel for airborne goods to reduce emissions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Apr 8, 2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees